131 related articles for article (PubMed ID: 2355780)
1. [Chronic myeloproliferative syndromes and tuberculosis: apropos of 3 cases].
Peró Silva A; García Saavedra V; Llorente Cabrera A
Med Clin (Barc); 1990 Apr; 94(15):582-4. PubMed ID: 2355780
[TBL] [Abstract][Full Text] [Related]
2. [Tuberculosis in chronic myeloproliferative syndromes: its incidence and principle characteristics in a series of 562 patients].
Tassies D; Cervantes F; Nicolás JM; Feliu E; Soriano E; Rozman C
Med Clin (Barc); 1991 Mar; 96(9):321-3. PubMed ID: 2046440
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients.
Aljurf M; Gyger M; Alrajhi A; Sahovic E; Chaudhri N; Musa M; Ayoub O; Seth P; Aslam M; Al-Fiar F
Bone Marrow Transplant; 1999 Sep; 24(5):551-4. PubMed ID: 10482941
[TBL] [Abstract][Full Text] [Related]
6. The chronic myeloproliferative disorders: an historical perspective.
Steensma DP
Curr Hematol Rep; 2003 May; 2(3):221-30. PubMed ID: 12901343
[TBL] [Abstract][Full Text] [Related]
7. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
8. Megakaryoblastic termination of myeloproliferative disorders.
Amin MB; Maeda K; Carey JL; Babu RV; Raman BK
Henry Ford Hosp Med J; 1992; 40(1-2):122-6. PubMed ID: 1428963
[TBL] [Abstract][Full Text] [Related]
9. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
10. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
11. [An unusual chronic myeloproliferation].
Kolesková E; Háber J; Klener P
Vnitr Lek; 1989 May; 35(5):489-92. PubMed ID: 2763484
[TBL] [Abstract][Full Text] [Related]
12. The role of beta-catenin in chronic myeloproliferative disorders.
Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
[TBL] [Abstract][Full Text] [Related]
13. Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders.
Cortes J; Kantarjian H
Cancer; 2004 May; 100(10):2064-78. PubMed ID: 15139047
[TBL] [Abstract][Full Text] [Related]
14. [Pneumoconiosis and mycobacterial infection].
Kekkaku; 2003 Nov; 78(11):711-5. PubMed ID: 14672049
[TBL] [Abstract][Full Text] [Related]
15. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
Nakata Y
Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
[TBL] [Abstract][Full Text] [Related]
16. [Platelet defects in chronic myeloproliferative disorders].
Raszeja-Specht A; Skibowska A; Kabata J; Hellmann A
Acta Haematol Pol; 1994; 25(3):253-60. PubMed ID: 7992598
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
[TBL] [Abstract][Full Text] [Related]
18. Myeloproliferative neoplasms cause glomerulopathy.
Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
[TBL] [Abstract][Full Text] [Related]
19. A myeloproliferative disorder may hide another one.
Laibe S; Tadrist Z; Arnoulet C; Sainty D; Mozziconacci MJ
Leuk Res; 2009 Aug; 33(8):1133-6. PubMed ID: 19250672
[TBL] [Abstract][Full Text] [Related]
20. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]